Nordic Bioproducts Group Receives Pharmaceutical Industry’s EXCiPACT™ Certification for MCC Production at Lappeenranta Facility
The Finnish company’s new factory has received the prestigious certification after being thoroughly audited by a recognized international entity. Nordic Bioproducts Group’s product offers the perfect solution for the pharmaceutical industry, combining quality and sustainability.Espoo, Finland [26.6.2024] – Nordic Bioproducts Group today announces that its new manufacturing factory in Lappeenranta, Finland, has received the prestigious EXCiPACT™ certification for the production of microcrystalline cellulose (MCC). This certification is a testament to its